Many patients find that addressing these foundational elements alongside their medication leads to better outcomes
Wegovy, in particular, has been approved by the FDA for weight management in mature individuals with obesity or overweight with at least one weight-related condition, such as high blood pressure or type 2 diabetes
Benefits Timeline Week 1-2: Food noise reduction, quieting of cravings begins Month 1: 2-4 pound loss typical, nausea under 10% for microdosers Month 3: 5-8% total body weight loss sustained Microdosing can support natural satiety and mindful eating, making it easier to build sustainable healthy habits rather than relying solely on the medication
Potential interactions to discuss with your provider Niacinamide has a minimal interaction profile, but a few situations warrant attention: Diabetes medications: Niacinamide may influence blood sugar levels
As a glucagon-like peptide-1 (GLP-1) receptor agonist, Wegovy mimics the GLP-1 hormone in the body and, in doing so, suppresses appetite and slows gastric (stomach) emptying